Document is current
Any future updates will be listed below
-
Authors
Thiruvengadam, Ramachandran
Rizvi, Zaigham Abbas
Raghavan, Sreevatsan
Murugesan, Deepika Rathna
Gosain, Mudita
Dandotiya, Jyotsna
Ayushi,
Samal, Sweety
Pandey, Anil K.
Wadhwa, Nitya
Bhatnagar, Shinjini
Awasthi, Amit
Garg, Pramod Kumar
-
Funding
Funding for this research was provided by:
Department of Biotechnology, Ministry of Science and Technology, India (102/IFD/SAN/5477/2018-2019)
Bill and Melinda Gates Foundation (INV-030592)
- License Information
-
More Information
Article History
Received: 10 November 2022
Accepted: 18 September 2023
First Online: 11 October 2023
Declarations
:
: This observational cohort study was approved by the Institute Ethics Committees of the partnering institutions: ‘Institutional Ethics Committee—Biomedical and Health Research’, Translational Health Science and Technology Institute and ‘Institutional Ethics Committee’, ESIC Medical College & Hospital, Faridabad. All the experimental protocols, animal challenge and necropsy were approved by Translational health Science and Technology Institute (THSTI) Institutional Animal Ethics Committee (IAEC), Institutional Biosafety (IBS) and Review Committee on Genetic Manipulation (RCGM). Informed consent was obtained from all individual participants included in the study.
: Not applicable as no patient identifiable data are presented in this paper.
: The authors declare no competing interests.
